-
Catalysts Growing Like Weeds For Zynerba Next Quarter
Tuesday, May 9, 2017 - 3:26pm | 372Despite confirming third-quarter catalysts and progress throughout its development pipeline, Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE)’s first-quarter financial report didn’t impress investors. The company conceded an 8.3-percent stock decline Tuesday even as it boasts a 22-percent...